Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: A systematic review

BMC Geriatrics

Volumn 19, Issue 1, 2019, Pages

  Ulley, Joanna ^a   Harrop, Deborah ^b   Ali, Ali ^a   Alton, Sarah ^a   Fowler Davis, Sally ^b  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

Adherence; Deprescribing; Older person; Polypharmacy; Systematic review

Indexed keywords

ADVERSE DRUG REACTION; AGED; COHORT ANALYSIS; COMORBIDITY; DEPRESCRIPTION; GENERAL PRACTITIONER; HUMAN; INDEPENDENT LIVING; MEDICATION COMPLIANCE; MIDDLE AGED; POLYPHARMACY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; DEPRESCRIPTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GENERAL PRACTITIONERS; HUMANS; INDEPENDENT LIVING; MEDICATION ADHERENCE; MIDDLE AGED; POLYPHARMACY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85060133431     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/s12877-019-1031-4     Document Type: Article

References (64)

1. Cramer J, Roy A, Burrell A, Fairchild C, Fuldeore M, Ollendorf D, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44-7.
2. World Health Organization. Adherence to Long Term Therapies. Geneva: Evidence for Action; World Health Organization; 2003. http://www.who.int/chp/knowledge/publications/adherence-report/en.
3. Kardas P, Lewekm P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.
4. Patton DE, Hughes CC, Ryan M. Theory-based interventions to improve medication adherence in older adults prescribed polypharmacy: a systematic review. Drugs Aging. 2017;34(2):97-113.
5. Laufs U, Rettig-Ewen V, Böhm M. Strategies to improve drug adherence. Eur Heart J. 2011;32(3):264-8.
6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
7. Mickelson RS, Holden RJ. Medication adherence: staying within the boundaries of safety. Ergonomics. 2018;61(1):82-103.
8. Pérez-Jover V, Mira JJ, Carratala-Munuera C, Gil-Guillen VF, Basora J, López-Pineda A, et al. Inappropriate use of medication by elderly, polymedicated, or multipathological patients with chronic diseases. Int J Enviro Res Public Health. 2018;15(2):310.
9. Vlasnik JJ, Aliotta SL, DeLor B. Medication adherence: factors influencing compliance with prescribed medication plans. Case Manager. 2005;16(2):47-51.
10. Rambhade S, Chakarborty A, Shrivastava A, Patil UK, Rambhade A. A survey on polypharmacy and use of inappropriate medications. Toxicol Int. 2012;19(1):68-73.
11. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regime complexity. Am J Geriatr Pharmacother. 2011;9(1):11-23.
12. Zelko E, Klemenc-Ketis Z, Tusek-Bunc K. Medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies. Mater Sociomed. 2016;28(2):129-32.
13. George J, Elliott RA, Stewart DC. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging. 2008;25(4):307-24.
14. Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med. 2015;13(1):74.
15. Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-34.
16. Page AT, Potter K, Clifford R, Etherton-Beer C. Deprescribing in older people. Maturitas. 2016 Sep 1;91:115-34.
17. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony DO. STOPP (screening tool of older Person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72-83.
18. Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy Guidance (2nd edition). 2015. Scottish Government. http://www.sehd.scot.nhs.uk/publications/DC20150415polypharmacy.pdf.
19. National Institute for Clinical Excellence. Multimorbidity: clinical assessment and management' NICE Guideline [NG56]. 2016. https://www.nice.org.uk/guidance/ng56.
20. National Institute for Clinical Excellence. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes'NICE guideline (NG5) publication date March 2015. https://www.nice.org.uk/guidance/ng5.
21. Raae-Hansen C, Byrne S, O'Mahony D, Kearney PM, Sahm LJ, Cullinan S. Challenges of deprescribing in older patients with multimorbidity, from healthcare professionals' perspectives-a narrative review. Pharmacoepidemiol Drug Saf. 2017;26(Suppl 1):16-7.
22. Scott IA, Anderson K, Freeman CR, Stowasser DA. First do no harm: a real need to deprescribe in older patients. Med J Aust. 2014;201(7):390-2.
23. Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. Journal Pharm Pract Res. 2003;33(4):323-8.
24. Kua CH, Yeo CYY, Char CWT, Tan CWY, Tan PC, Mak VS, et al. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol. BMJ Open. 2017;7(5):e015293.
25. Masnoon N, Shakib S, Kalisch L, Caughey G. Systematic review of polypharmacy definition, assessment tools, and association with clinical outcomes. Res Soc Admin Pharm. 2017;13(4):e28-9.
26. Mortazavi SS, Shati M, Keshtkar A, Malakouti SK, Bazargan M, Assari S. Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open. 2016;6(3):e010989.
27. Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Inf Libr J. 2009;26(2):91-108.
28. Pharmaceutical Care Network Europe 'PCNE statement on medication review' v3.01012013 https://www.pcne.org/upload/files/150-20160504-PCNE-MedRevtypes.pdf.
29. Pluye P, Robert E, Cargo M, Bartlett G, O'Cathain A, Griffiths F, et al. Proposal: A mixed methods appraisal tool for systematic mixed studies reviews. 2011. http://mixedmethodsappraisaltoolpublic.pbworks.com/w/file/fetch/84371689/MMAT%202011%20criteria%20and%20tutorial%202011-06-29updated2014.08.21.pdf. Archived by WebCite® at http://www.webcitation.org/5tTRTc9yJ.
30. Ritchie J, Spencer L. Qualitative Data Analysis for Applied Policy Research. In: Bryman A, Burgess B, editors. Analyzing Qualitative Data. London: Routledge: Chapter 9. Routledge, London; 1994.
31. O'Cathain A, Murphy E, Nicholl J. Three techniques for integrating data in mixed methods studies. BMJ. 2010;341(7783):1147.
32. Campins L, Serra-Prat M, Gózalo I, López D, Palomera E, Agustí C, et al. Randomized controlled trial of an intervention to improve drug appropriateness in community-dwelling polymedicated elderly people. Fam Pract. 2017;34(1):36-42.
33. Haag JD, et al. Impact of Pharmacist-Provided medication therapy management on healthcare quality and utilisation in recently discharged elderly patients. Am Health Drug Benefits. 2016;9(5):259-68.
34. Basheti IA, Al-Qudah R, Obeidat NM, Bulatova NR. Home medication management review in outpatients with chronic diseases in Jordan: a randomized control trial. Int J Clin Pharm. 2016;38(2):404-13.
35. Chen C, Kuo L, Cheng K, Shen W, Bai K, Wang C, et al. The effect of medication therapy management service combined with a national PharmaCloud system for polypharmacy patients. Comput Methods Prog Biomed. 2016;134:109-19.
36. Hedegaard U, Kjeldsen LJ, Pottegård A, Henriksen JE, Lambrechtsen J, Hangaard J, et al. Improving Medication Adherence in Patients with Hypertension: A Randomized Trial. Am J Med. 2015;128(12):1351-61.
37. Steele KM, Ruisinger JF, Bates J, Prohaska ES, Melton BL, Hipp S. Home-based comprehensive medication reviews: Pharmacist's impact on drug therapy problems in geriatric patients. Consult Pharm. 2016;31(10):598-605.
38. Lee VW, Choi LM, Wong WJ, Chung HW, Ng CK, Cheng FW. Pharmacist intervention in the prevention of heart failure for high-risk elderly patients in the community. BMC Cardiovasc Disord. 2015;15:178.
39. Twigg MJ, Wright D, Barton GR, Thornley T, Kerr C. The four or more medicines (FOMM) support service: results from an evaluation of a new community pharmacy service aimed at over-65s. Int J Pharm Pract. 2015;23(6):407-14.
40. Tan ECK, Stewart K, Elliott RA, George J. Pharmacist consultations in general practice clinics: the pharmacists in practice study (PIPS). Res Social Adm Pharm. 2014;10(4):623-32.
41. Hatah E, Tordoff J, Duffull SB, Cameron C, Braund R. Retrospective examination of selected outcomes of medicines use review (MUR) services in New Zealand. Int J Clin Pharm. 2014;36(3):503-12.
42. Roth MT, Ivey JL, Esserman DA, Crisp G, Kurz J, Weinberger M. Individualized medication assessment and planning: optimizing medication use in older adults in the primary care setting. Pharmacotherapy. 2013;33(8):787-97.
43. Vinks THAM, Egberts TCG, de Lange TM, de Koning FHP. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging. 2009;26(2):123-33.
44. Sturgess I, McElnay J, Hughes C, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25(5):218-26.
45. Grymonpre RE, Williamson DA, Montgomery PR. Impact of a pharmaceutical care model for non-institutionalised elderly: results of a randomised, controlled trial. Int J Pharm Pract. 2001;9(4):235-41.
46. Raynor DK, Nicolson M, Nunney J, Petty D, Vail A, Davies L. The development and evaluation of an extended adherence support programme by community pharmacists for elderly patients at home. Int J Pharm Pract. 2000;8(3):157-64.
47. Lowe CJ, Raynor DK, Purvis J, Farrin A, Hudson J. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol. 2000;50(2):172-5.
48. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100(4):428-37.
49. Fiβ T, Meinke-Franze C, van den Berg N, Hoffmann W. Effects of a three party healthcare network on the incidence levels of drug related problems. Int J Clin Pharm. 2013;35(5):763-71.
50. Jäger C, Freund T, Steinhaeuser J, Stock C, Krisam J, Kaufmann-Kolle P, et al. Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices-results of a cluster-randomized controlled trial. Implement Sci. 2017;12(1):8.
51. Griffiths R, Johnson M, Langdon R, Piper M. A nursing intervention for the quality use of medicines by elderly community clients. Int J Nurs Pract. 2004;10(4):166-76.
52. Beer C, Loh P, Peng YG, Potter K, Millar A. A pilot randomized controlled trial of deprescribing. Ther Adv Drug Saf. 2011;2(2):37-43.
53. Messerli BE, Vriends N, Hersberger KE. Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial. BMC Health Serv Res. 2016;16:145.
54. de Wit L, Fenenga C, Giammarchi C, di Furia L, Hutter I, de Winter A, et al. Community-based initiatives improving critical health literacy: a systematic review and meta-synthesis of qualitative evidence. BMC Public Health. 2018;18:40.
55. Marcum ZA, Hanlon JT, Murray MD. Improving medication adherence and health outcomes in older adults: an evidence-based review of randomized controlled trials. Drugs Aging. 2017;34(3):191-201.
56. Health and Care Professions Council. Standards for prescribing. No date. https://www.hcpc-uk.org/resources/standards/standards-for-prescribing/.
57. Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016 Sep 1;82(3):583-623.
58. Tan EC, Sluggett JK, Johnell K, Onder G, Elseviers M, Morin L, et al. Research priorities for optimizing geriatric pharmacotherapy: an international consensus. J Am Med Dir Assoc. 2018;19(3):193-9.
59. Thillainadesan J, Gnjidic D, Green S, Hilmer SN. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials. Drugs Aging. 2018;35(4):303-19.
60. Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28(2):237-53.
61. Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J of Clin Pharmacol. 2016;82(3):583-623.
62. Thomas R, Huntley AL, Mann M, Huws D, Elywn G, Paranjothy S, et al. Pharmacist-led interventions to reduce unplanned admissions for older people: a systematic review and meta-analysis of randomised controlled trials. Age Ageing. 2014;43(2):174-87.
63. Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: A systematic review. Drugs Aging. 2013;30:793-807.
64. Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, et al. Clinical medication review by a pharmacist of elderly people living in care homes-a randomised controlled trial. Age Ageing. 2006;35(6):586-91.